Updated Jul 16, 2026
Jordt Raymond M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Raymond M. Jordt is the Chief Business Officer at Altimmune, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's strategic business initiatives, although specific notable achievements are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-02 | ALT | Altimmune, Inc. | A — Grant or award | 4.6K | $3.07 | $14K |
| 2026-01-29 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 4.2K | $6.18 | $26K |
| 2026-01-29 | ALT | Altimmune, Inc. | M — Option exercise | 15.8K | $0.00 | |
| 2026-01-27 | ALT | Altimmune, Inc. | F — Tax withholding / forfeiture | 3.9K | $5.50 | $21K |
| 2026-01-27 | ALT | Altimmune, Inc. | M — Option exercise | 14.6K | $0.00 | |
| 2025-07-31 | ALT | Altimmune, Inc. | A — Grant or award | 1.4K | $3.14 | $4K |
Raymond M. Jordt is the Chief Business Officer at Altimmune, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's strategic business initiatives, although specific notable achievements are not widely documented.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jordt Raymond M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.